Voreloxin
Voreloxin (SNS-595) is a topoisomerase II-targeting anticancer agent with broad-spectrum activity. It has demonstrated efficacy in preclinical in vitro and in vivo models against various cancers, including acute myeloid leukemia and solid tumors, supporting its research use in oncology and pharmacology studies.
Product Specifications
CAS Number
175414-77-4
Field of Research
Cell Biology, Molecular Biology
Smiles
CN[C@H]1CN (C[C@@H]1OC) C2=NC3=C (C=C2) C (=O) C (=CN3C4=NC=CS4) C (=O) O
Molecular Formula
C18H19N5O4S
Molecular Weight
401.44
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6300047-01 0.2 mL
FPR1, ID (FPR1, fMet-Leu-Phe receptor, N-formyl peptide receptor, N-formylpeptide chemoattractant receptor) (PE)
Sign In for Pricing
View Details MBS6300047-02 5x 0.2 mL
FPR1, ID (FPR1, fMet-Leu-Phe receptor, N-formyl peptide receptor, N-formylpeptide chemoattractant receptor) (PE)
Sign In for Pricing
View Details